Portal de Periódicos da CAPES

Universal WBC reduction and patient advocacy

2000; Wiley; Volume: 40; Issue: 12 Linguagem: Inglês

10.1046/j.1537-2995.2000.40121545.x

1537-2995

Dennis Goldfinger, Ellen Klapper, Samuel H. Pepkowitz, Sanford I. Millar, Joanna M. Heal, Neil Blumberg, David Wuest, Lilian Reich, Klaus Mayer,

Parvovirus B19 Infection Studies

TransfusionVolume 40, Issue 12 p. 1545-1546 Universal WBC reduction and patient advocacy Dennis Goldfinger MD, Dennis Goldfinger MD Division of Transfusion Medicine Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los Angeles, CASearch for more papers by this authorEllen Klapper MD, Ellen Klapper MD Division of Transfusion Medicine Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los Angeles, CASearch for more papers by this authorSamuel H. Pepkowitz MD, Samuel H. Pepkowitz MD Division of Transfusion Medicine Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los Angeles, CASearch for more papers by this authorSanford I. Millar JD, Sanford I. Millar JD Attorney at Law Los Angeles, CASearch for more papers by this authorJoanna M. Heal MRCP, Joanna M. Heal MRCP Departments of Medicine and Pathology and Laboratory Medicine University of Rochester Medical Center Rochester, NYSearch for more papers by this authorNeil Blumberg MD, Neil Blumberg MD Departments of Medicine and Pathology and Laboratory Medicine University of Rochester Medical Center Rochester, NYSearch for more papers by this authorDavid Wuest MD, David Wuest MD Departments of Medicine and Clinical Laboratories Memorial Sloan Kettering Cancer Center New York, NYSearch for more papers by this authorLilian Reich MD, Lilian Reich MD Departments of Medicine and Clinical Laboratories Memorial Sloan Kettering Cancer Center New York, NYSearch for more papers by this authorKlaus Mayer MD, Klaus Mayer MD Departments of Medicine and Clinical Laboratories Memorial Sloan Kettering Cancer Center New York, NYSearch for more papers by this author Dennis Goldfinger MD, Dennis Goldfinger MD Division of Transfusion Medicine Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los Angeles, CASearch for more papers by this authorEllen Klapper MD, Ellen Klapper MD Division of Transfusion Medicine Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los Angeles, CASearch for more papers by this authorSamuel H. Pepkowitz MD, Samuel H. Pepkowitz MD Division of Transfusion Medicine Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los Angeles, CASearch for more papers by this authorSanford I. Millar JD, Sanford I. Millar JD Attorney at Law Los Angeles, CASearch for more papers by this authorJoanna M. Heal MRCP, Joanna M. Heal MRCP Departments of Medicine and Pathology and Laboratory Medicine University of Rochester Medical Center Rochester, NYSearch for more papers by this authorNeil Blumberg MD, Neil Blumberg MD Departments of Medicine and Pathology and Laboratory Medicine University of Rochester Medical Center Rochester, NYSearch for more papers by this authorDavid Wuest MD, David Wuest MD Departments of Medicine and Clinical Laboratories Memorial Sloan Kettering Cancer Center New York, NYSearch for more papers by this authorLilian Reich MD, Lilian Reich MD Departments of Medicine and Clinical Laboratories Memorial Sloan Kettering Cancer Center New York, NYSearch for more papers by this authorKlaus Mayer MD, Klaus Mayer MD Departments of Medicine and Clinical Laboratories Memorial Sloan Kettering Cancer Center New York, NYSearch for more papers by this author First published: 25 April 2002 https://doi.org/10.1046/j.1537-2995.2000.40121545.xCitations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1 Thurer RL, Luban NLC, AuBuchon JP, et al. Universal WBC reduction (letter). Transfusion 2000; 40: 751– 2. 2 Holmes S. Airbus has a lot riding on new jumbo as it seeks to jettison No. 1 Boeing. Los Angeles Times, 2000;July 23:C[Business]1. 3 Goldfinger D, Lowe C. A critical analysis of saline washed red blood cells with special reference to their ability to prevent adverse reactions to blood transfusion. In: HF Polesky, RH Walker, eds. Safety in transfusion practices. Skokie, IL: College of American Pathologists, 1982: 205– 22. 4 Broers AE, Van Der Holt R, Van Esser JW, et al. Increased transplant-related morbidity and mortality in CMV-sero-positive patients despite highly effective prevention of CMV disease after allogeneic T-cell depleted stem cell transplantation. Blood 2000; 95: 2240– 5. 5 Wolfe CFW, Canale VC. Fatal pulmonary hypersensitivity reaction to HL-A incompatible blood transfusion: report of a case and review of the literature. Transfusion 1976; 16: 135– 40. 6 Goldfinger D, Haimowitz M. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Pro. Transfusion 1994; 34: 75– 8. 7 Ness PM. Integrating the new generation of blood components into transfusion practice. Transfusion 1999; 39: 1027– 30. Citing Literature Volume40, Issue12December 2000Pages 1545-1546 ReferencesRelatedInformation